Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 5 | 2017 | 310 | 0.510 |
Why?
|
| Breast Neoplasms, Male | 1 | 2010 | 12 | 0.360 |
Why?
|
| Hemangioma, Cavernous | 1 | 2010 | 5 | 0.360 |
Why?
|
| Ultrasonography, Mammary | 3 | 2013 | 39 | 0.300 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2021 | 62 | 0.290 |
Why?
|
| Breast Density | 2 | 2017 | 21 | 0.280 |
Why?
|
| Breast Diseases | 2 | 2016 | 40 | 0.250 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 1536 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 772 | 0.200 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 33 | 0.190 |
Why?
|
| Awards and Prizes | 1 | 2019 | 27 | 0.170 |
Why?
|
| Radiology | 2 | 2017 | 97 | 0.170 |
Why?
|
| Physicians | 1 | 2019 | 324 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 177 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 237 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 504 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 57 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 142 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2012 | 129 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 191 | 0.090 |
Why?
|
| Middle Aged | 6 | 2017 | 21147 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1140 | 0.070 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.050 |
Why?
|
| Humans | 8 | 2021 | 68618 | 0.050 |
Why?
|
| Neoplasm, Residual | 1 | 2021 | 33 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 64 | 0.050 |
Why?
|
| Mastectomy | 1 | 2021 | 57 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 4848 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 7277 | 0.040 |
Why?
|
| Reoperation | 1 | 2021 | 467 | 0.040 |
Why?
|
| Leadership | 1 | 2019 | 136 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2019 | 403 | 0.040 |
Why?
|
| Adult | 4 | 2016 | 21403 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 83 | 0.030 |
Why?
|
| Premenopause | 1 | 2016 | 57 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Postmenopause | 1 | 2016 | 93 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 330 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2016 | 110 | 0.030 |
Why?
|
| Calcinosis | 1 | 2016 | 241 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 540 | 0.030 |
Why?
|
| Aged | 3 | 2016 | 14862 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 287 | 0.030 |
Why?
|
| Male | 2 | 2019 | 37321 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 729 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1753 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 800 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.020 |
Why?
|
| United States | 1 | 2016 | 7367 | 0.010 |
Why?
|
| Child | 1 | 2013 | 6405 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8912 | 0.010 |
Why?
|